Skip to main content

ISRG STOCK WRITE UP


ISRG (INTUITIVE SURGICAL INC)

  • P/E: 48
  • GAAP DILUTED YEAR-OVER-YEAR EPS GROWTH LAST QUARTER: $1.13
  • SECTOR: HEALTH TECHNOLOGY
  • ASSETS-LIABILITIES: 7.05
  • DIVIDEND: none

ISRG is the ticker for Intuitive Surgical Inc, a company endeavoring in the manufacture and distribution of robotic surgical devices. The company recently gained FDA approval for a lower-cost device. They have a clean balance sheet with a history of upside surprises against earnings expectations, and report again 7/20/17.
Revenues increased nearly 14%, while EPS increased 32% compared to the Q1 '16 results. While liabilities decreased on a year-over-year basis, assets decreased by a larger margin. R&D spending increased 36%, and administrative costs rose 16%. Taxes were cut in half, although the revenues increased, due to modified accounting principles, and tax benefits for the employee share-based compensation.. The ratio of assets-liabilities decreased from 9.14 to 7.05, which is still a considerable margin. ISRG increased their share buyback by a multiple of 250 on a year-over-year basis, and divested investment assets to free cash for employee share compensation, as well.
Some health professionals have stated that Intuitive Surgical's Davinci surgery system is not beneficial, as a surgeon still must control the device's robotic arms. Davinci is most useful for minimally invasive gynecological and urological procedures which utilize robotic arms to avoid human error. For surgeries in which the doctor is capable of performing the operation reasonably manually, there is no practical application for a $2 million device to replicate the movements via remote control. A study showed that minimally invasive urological procedures performed with Davinci led to reduced recovery time, with a similarly favorable result. Increased demand for the product's use in gynecological procedures, general surgery, urological operations, and kidney cancer applications led to a nearly 21% increase in global Davinci unit shipments.
Gary Guthart has been the company's CEO since 2010. He has been with the company since 1996, he holds a BS and PhD, and worked with computer-assisted surgery at Stanford Research Institute prior to joining ISRG. The Davinci X surgical system received FDA clearance 5/31/17. Guthart states that the Davinci X is designed to provide services at a lower price point. This will provide an opportunity to provide services to clients who may not benefit enough from the system to justify a $2 million expenditure.
Although there are no direct competitors which can be utilized for stock valuation comparison, it is important to note that Medtronics, Alphabet Inc, and Johnson and Johnson all have connections with smaller surgical robotics companies. ISRG trades at a premium to the average S&P stock with a P/E of 48, but its growth rate is also above average at 14% revenue and 32% EPS growth. ISRG has beat wall street expectations in each of the last 8 quarters, propelling expectations higher with each quarterly report.







https://www.estimize.com/isrg

Labels:

Comments

Post a Comment

Popular posts from this blog

CTAS STOCK WRITE UP

CTAS (CINTAS CORPORATION) P/E: 26.8 GAAP DILUTED YEAR-OVER-YEAR EPS GROWTH LAST QUARTER: $.02 SECTOR: CONSUMER SERVICES ASSETS-LIABILITIES: 2.09 DIVIDEND: 1.06% CTAS is a company providing uniforms to major companies. They report 7/20/17 after the market close. The company is profitable, and has acquired smaller businesses to grow its revenue, while selling a paper-shredding company it had previously acquired. The company has more cash than debt. Inventories increased by 9%, and revenue increased by 5.3%. Income before taxes grew 2.5%, and $642,000 in losses from discontinued operations and a $9 million acquisition expense reduced the profit improvement to just under 2%. The majority of revenue is derived from uniform rental services. According to wikinvest, CTAS has 30% of market share for uniform rentals due to its commitment to providing specialized products to fit customer needs. Cintas was founded as The Acme Industrial Laundry Company in 19...
5 comments
Read more

ONE UP ON WALL STREET SUMMARY

ONE UP ON WALL STREET PETER LYNCH SUMMARY Lynch opens the book with the contention that the average investor can perform as well as most experts.  He dubs stocks that earn ten times of initial investment amount as "tenbaggers."  Money for investing can be saved through minor lifestyle adjustments.  Although the author attends many functions with high-level market professionals, he still finds many of his stock picks in his everyday life.  The novel is divided into three portions: preparing to invest, picking winners, and long-term view.  He states that there is no such thing as a born stockpicker, and that picking stocks is an art rather than a science, and as such cannot be quantified. The author worked as a caddy in his youth and traded golfing advice for stock picks.  He utilizes the term "street lag" to describe the amount of time between when consumers recognize a good product and when wall street recognizes the company.  Some stock...
Post a Comment
Read more